Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial.

Vorapaxar, a platelet thrombin-receptor antagonist, in medically managed patients with non-ST-segment elevation acute coronary syndrome: results from the TRACER trial. Eur Heart J Acute Cardiovasc Care. 2014 Sep; 3(3):246-56.

View in: PubMed

subject areas

Acute Coronary Syndrome
Aged
Double-Blind Method
Female
Hemorrhage
Humans
Lactones
Male
Middle Aged
Myocardial Infarction
Platelet Aggregation Inhibitors
Pyridines
Recurrence
Risk Factors
Stroke
Treatment Outcome

authors with profiles

Robert Harrington